We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MRI Virtual Biopsy to Transform Heart Transplant Care

By MedImaging International staff writers
Posted on 30 May 2022
Print article
Image: New virtual biopsy detects any signs of the heart being rejected (Photo courtesy of Unsplash)
Image: New virtual biopsy detects any signs of the heart being rejected (Photo courtesy of Unsplash)

Most patients who receive heart transplants experience some form of organ rejection and whilst survival rates are high, a small percentage will die in the first year after surgery. Most clinicians around the world currently test for rejection by performing a biopsy which helps determine the level and suitability of immunosuppressive treatments needed to treat and prevent further rejection. This invasive procedure involves a tube being placed in the jugular vein to allow surgeons to insert a biopsy tool into the heart to remove multiple samples of heart tissue. As well as being uncomfortable, it can also lead to rare but serious complications if the heart is perforated, or a valve is damaged. Patients usually undergo a biopsy around 12 times in the first year after transplantation. But the days of heart transplant survivors undergoing invasive biopsies could soon be over after a new MRI technique has proven to be safe and effective; reducing complications and hospital admissions.

Scientists at the Victor Chang Cardiac Research Institute (Sydney, Australia) have developed the new virtual biopsy designed to detect any signs of the heart being rejected will be adopted by clinicians the world over. The new MRI technique has been proven to be accurate in detecting rejection and works by analyzing heart oedema levels which the team demonstrated are closely associated with inflammation of the heart. The new development will lead to major improvements in care for many thousands of heart transplant patients worldwide.

In a study, 40 heart transplant patients were randomized into receiving either a traditional biopsy or the new MRI technique. Results revealed the new test was just as effective as detecting rejection. Secondary findings of the study revealed that despite similarities in immunosuppression requirements, kidney function and mortality rates, there was a reduction in hospitalization and infection rates for those who underwent the MRI procedure vs. a biopsy. Also, just 6% of the patients having the new MRI technique needed a biopsy for clarification reasons. These secondary findings are earmarked to be reconfirmed in planned larger multi-centre studies.

The team is now planning a larger multi-centre trial to broaden the applicability of the findings and incorporate pediatric transplant recipients. They are also developing new genetic testing to be used alongside the MRI which it is hoped will detect signs of rejection through identifying genetic signals of donor-specific inflammation in the bloodstream. The new technique will also be adapted to detect heart inflammation in the wider population, not just transplant recipients.

“It’s essential that we can monitor these patients closely and with a high degree of accuracy; now we have a new tool that can do that without the need for a highly invasive procedure,” said Associate Professor Andrew Jabbour, of the Victor Chang Cardiac Research Institute. “This new virtual biopsy takes less time, is non-invasive, more cost-effective, uses no radiation or contrast agents, and most importantly patients much prefer it.”

Related Links:
Victor Chang Cardiac Research Institute 

Gold Supplier
128 Slice CT Scanner
Supria 128
Gold Supplier
Conductive Gel
Tensive
New
Cart-Based Ultrasound System
SonoMax 9
New
Diagnostic Ultrasound System
DRE Crystal 4P

Print article
Sun Nuclear -    Mirion

Channels

Radiography

view channel
Image: Radiologists outperformed AI in identifying lung diseases on chest X-ray (Photo courtesy of RSNA)

Radiologists Beat AI in Detecting Common Lung Diseases on Chest X-Rays

Chest X-rays are frequently used for diagnosis, but it takes a lot of training and expertise to read these images correctly. Although the Food and Drug Administration (FDA) has approved some artificial... Read more

Ultrasound

view channel
Image: The new device targets ultrasound waves to precise spots in the brain (Photo courtesy of WUSTL)

Anatomically Precise Ultrasound-Based Technique to Enable Noninvasive Biopsies for Brain Tumors

The blood-brain barrier serves as a protective wall, keeping the brain safe from harmful elements like viruses and toxins in the blood. This makes it challenging for doctors to obtain molecular and genetic... Read more

Nuclear Medicine

view channel
Image: Imaging entire body instead of only the primary cancer site can provide a total estimate of HER2 expression (Photo courtesy of 123RF)

Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients

Around 20% of women diagnosed with breast cancer show overexpression of human epidermal growth factor receptor 2 (HER2), making it a key therapy target for new as well as recurring cases.... Read more

General/Advanced Imaging

view channel
Image: Annalise Enterprise CTB acts like a ‘second pair of eyes’ for radiologists (Photo courtesy of Annalise.ai)

Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

Non-contrast computed tomography of the brain (NCCTB) is a commonly employed method for identifying intracranial pathology. Despite its frequent use, the complex scan outcomes are prone to being misunderstood.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The partnership combines best-in-class AI-powered technologies for musculoskeletal imaging workflows (Photo courtesy of ImageBiopsy Lab)

AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis

Musculoskeletal (MSK) conditions impact more people worldwide than issues related to the circulatory or respiratory systems. Even so, diagnostic procedures for these conditions often still lean on outdated... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.